Company intelligence / Profile preview
Laverock Therapeutics
Stevenage, England, United Kingdomlaverocktx.com ↗
- Ownership
- Private
- Development stage
- Preclinical
01
Overview
Laverock has demonstrated proof-of-concept that its GEiGS® gene silencing technology can be translated from plants to humans, with preclinical data supporting programmable, multiplexed gene silencing in iPSC-derived cells. Early results show potential for tunable control of immune cell function and disease-specific targeting. No clinical trial results yet.
- Therapeutic areas
- OncologyEndocrinologyRare Diseases
- Modalities
- Gene silencing (RNAi, microRNAs)Allogeneic cell therapies (iPSC-derived)CRISPR gene editing
- Industry
- Biotech
02
Drug pipeline
4 assets3 more assets in the full pipeline.
Request access →03
Partnerships
Tropic Biosciences – exclusive license to GEiGS® technology for human therapeutic use [6].Academic collaborations possible but not specified.Investors include Eli Lilly & Company, Innovate UK, Tekfen Ventures, Mercia Ventures, Maven Capital Partners among others [2].
Beyond the preview
Go deeper on Laverock Therapeutics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Laverock Therapeutics.